Skin inflammatory response and efficacy of anti-epidermal growth factor receptor therapy in metastatic colorectal cancer (CUTACETUX)
Anti-epidermal growth factor receptor (EGFR) monoclonal antibody is a standard treatment of metastatic colorectal cancer (mCRC) and its most common adverse effect is a papulopustular acneiform rash. The aim of the CUTACETUX study was to characterize the skin inflammatory response associated with thi...
Main Authors: | David Tougeron, Sheik Emambux, Laure Favot, Thierry Lecomte, Ewa Wierzbicka-Hainaut, Mahtab Samimi, Eric Frouin, Nicolas Azzopardi, Jocelyn Chevrier, Laura Serres, Julie Godet, Pierre Levillain, Gilles Paintaud, Aurélie Ferru, Laetitia Rouleau, Adriana Delwail, Christine Silvain, Jean-Pierre Tasu, Franck Morel, Stéphanie Ragot, Jean-Claude Lecron |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-01-01
|
Series: | OncoImmunology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/2162402X.2020.1848058 |
Similar Items
-
Pathological and Molecular Characteristics of Colorectal Cancer with Brain Metastases
by: Pauline Roussille, et al.
Published: (2018-12-01) -
Analysis of factors influencing molecular testing at diagnostic of colorectal cancer
by: Quentin Thiebault, et al.
Published: (2017-11-01) -
The Gambia hepatitis intervention study (GHIS)
by: Pierre Hainaut
Published: (2007-02-01) -
Hepatitis infections, aflatoxin and hepatocellular carcinoma
by: Pierre Hainaut
Published: (2007-02-01) -
Interplay between viral infections and genetic alterations in liver cancer
by: Pierre Hainaut
Published: (2007-02-01)